Uncategorized

ANGLE plc, a world-leading liquid biopsy company, will be releasing its preliminary results for the year ended 31 December 2022 on Friday 21 April 2023.

REGiMMUNE Limited, a biotech company focused on creating innovative immunotherapies for immune disorders and cancer, and San Fu Biotech, a subsidiary of San Fu Chemical Co., Ltd. have entered a licensing agreement to develop and commercialize RGI-2001 for the prophylaxis of acute Graft-versus-host disease in major Asian countries.

Medtronic plc and DaVita Inc. announced the launch of Mozarc Medical—an independent new company committed to reshaping kidney health and driving patient-centered technology solutions.

AnPac Bio-Medical Science Co., Ltd. announced that it has entered into a securities purchase agreement with certain institutional investors to purchase $3.0 million of its American Depositary Shares, pre-funded warrants to purchase ADSs and warrants to purchase ADSs in a registered direct offering.

RELIEF THERAPEUTICS Holding SA announces the appointment of world-renowned gene therapy pioneer Guangping Gao, Ph.D. as the chair of the Company’s newly formed scientific advisory board.

Mabwell, an innovative biopharmaceutical company with the layout of whole industry chain, announced that the Denosumab solution for injection, which is developed by its wholly-owned subsidiary T-mab, has been formally approved for marketing by the National Medical Products Administration .

With several recent milestones, Intellia Therapeutics is setting a solid foundation for gene editing in rare diseases with an eye toward broader patient populations.

En este Short os hablamos del origen del agua como la que se halla presente en planetas como la Tierra.     …

Se recomienda la implementación temprana de estrategias nutricionales preventivas y valorar el papel fundamental de la microbiota intestinal

The DNA-sequencing company says Icahn’s board nominees don’t understand its business or the regulatory process.